Basiliximab Sarotalocan

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 12:29:50 GMT 2025` Edited by `admin` on `Wed Apr 02 12:29:50 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	CED3FF7MXQ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Basiliximab Sarotalocan

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CHI621 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CHI621 LIGHT CHAIN, DIMER, N6-(1-OXO-6-(((3-((29H,31H-PHTHALOCYANIN-1-YL-.KAPPA.N29,.KAPPA.N30,.KAP

Preferred Name

English

basiliximab sarotalocan [INN]

Common Name

English

Code System Code Type Description

NCI_THESAURUS

C199024

Created by admin on Wed Apr 02 12:29:50 GMT 2025 , Edited by admin on Wed Apr 02 12:29:50 GMT 2025

PRIMARY

CAS

2417483-64-6

Created by admin on Wed Apr 02 12:29:50 GMT 2025 , Edited by admin on Wed Apr 02 12:29:50 GMT 2025

PRIMARY

INN

12582

Created by admin on Wed Apr 02 12:29:50 GMT 2025 , Edited by admin on Wed Apr 02 12:29:50 GMT 2025

PRIMARY

FDA UNII

CED3FF7MXQ

Created by admin on Wed Apr 02 12:29:50 GMT 2025 , Edited by admin on Wed Apr 02 12:29:50 GMT 2025

PRIMARY

SMS_ID

300000051843

Created by admin on Wed Apr 02 12:29:50 GMT 2025 , Edited by admin on Wed Apr 02 12:29:50 GMT 2025

PRIMARY

From	To
4_131	4_191
4_23	4_87
3_131	3_191
3_23	3_87
2_220	4_211
1_220	3_211
1_229	2_229
1_226	2_226
2_367	2_425
2_261	2_321
2_144	2_200
2_22	2_96
1_367	1_425
1_261	1_321
1_144	1_200
1_22	1_96

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_297
N	2_297

Related Record Type Details


					08TF01H1UT

INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA

TARGET->LIGAND

Interaction Type:

PRECLINICAL

Amount:

Related Record Type Details


					CED3FF7MXQ

Basiliximab Sarotalocan

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION				Amount:	IRDYE 700DX LYSINE	L222H49G89
AMINO_ACID_SUBSTITUTION	[1_1] [2_1]	SITE_SPECIFIC			PIDOLIC ACID	SZB83O1W42
AMINO ACID REMOVAL	[1_447] [2_447]	C-TERMINUS			LYSINE	K3Z4F929H6

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL